会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • Circulation promoting laser irradiation device
    • 循环促进激光照射装置
    • US20070038274A1
    • 2007-02-15
    • US10555386
    • 2004-04-23
    • Takeo IshiiKunio Horiuchi
    • Takeo IshiiKunio Horiuchi
    • A61N5/06
    • A61N5/0616A61B2018/208A61N2005/063A61N2005/0662A61N2005/0663A61N2005/067
    • A circulation-accelerating light irradiation system capable of irradiating a focus part with light with such a wavelength as to show a high vasodilating action is provided. When a therapy start signal is inputted by the user or the like, a control unit 13 starts controlling a laser beam generation unit 12. The laser beam generation unit 12 generates laser beams 15 according to the control of the control unit 13. The laser beams 15 thus generated are transmitted through optical fibers 10, and are converted into parallel beams by collimator lenses 11. The laser beams 15 converted into the parallel beams are radiated onto a living body, and are concentrated onto a target part 51. The diseased part is treated with the energy of the concentrated laser beams 15. This makes it possible to set the output energy of each individual laser beam 15 to a low level, to reduce the influence of the laser beams 15 on the skin surface on which the laser beams are directly incident, and, on the other hand, to apply a sufficient optical energy to the diseased part 51.
    • 提供一种循环加速光照射系统,其能够以具有高血管扩张作用的波​​长的光照射聚焦部分。 当用户输入治疗开始信号等时,控制单元13开始控制激光束产生单元12。 激光束产生单元12根据控制单元13的控制产生激光束15。 这样产生的激光束15通过光纤10传输,并通过准直透镜11转换为平行光束。 被转换为平行光束的激光束15照射到生物体上,并被集中在目标部分51上。 用集中的激光束15的能量来处理患病部位。 这使得可以将每个单独的激光束15的输出能量设置为低水平,以减少激光束15对激光束直接入射的皮肤表面的影响,另一方面, 对患病部位51施加足够的光能。
    • 9. 发明授权
    • Platelet collecting apparatus
    • 血小板收集装置
    • US06893412B2
    • 2005-05-17
    • US09994696
    • 2001-11-28
    • Noboru SaitoTakeshi UdagawaKunio Horiuchi
    • Noboru SaitoTakeshi UdagawaKunio Horiuchi
    • A61M1/02A61B5/15A61M1/30A61M1/36B04B1/14A61M37/00B01D33/15C02F1/38
    • A61M1/3693A61M1/303A61M1/304A61M1/308A61M1/3696A61M2202/0415A61M2202/0427A61M2205/331A61M2205/3382A61M2205/50A61M2202/0014
    • A platelet collecting apparatus 1 comprises a centrifugal separator 20 possessing a rotatable rotor 142; a first line 21 for allowing the flow of the blood entering the centrifugal separator 20; a second line 22 for allowing the flow of the blood emanating from the centrifugal separator, a plasma collecting bag 25 connected to the first line 21 and the second line 22 so as to collect the plasma emanating from the centrifugal separator 20 and return the collected plasma to the centrifugal separator 20, a platelet collecting bag 26 connected to the second line 22 so as to collect the platelets emanating from the centrifugal separator 20, a blood delivering pump 11 disposed in the first line 21, and a controller 13 for controlling the operation of the rotor of the centrifugal separator 20 and the operation of the blood delivering pump 11. The controller 13 is endowed with a function of varying the rotational frequency of the rotor 142 during the course of blood collection in conformity with the amount of the blood entered into the centrifugal separator 20 via the first line 21.
    • 血小板收集装置1包括具有可旋转转子142的离心分离器20; 用于允许进入离心分离器20的血液流动的第一管线21; 用于允许从离心分离器发出的血液流动的第二管线22,连接到第一管线21和第二管线22的等离子体收集袋25,以收集从离心分离器20发出的等离子体并返回收集的等离子体 与离心分离器20连接的血小板收集袋26连接到第二管线22,以收集从离心分离器20发出的血小板,设置在第一管线21中的输血泵11和用于控制操作的控制器13 离心分离器20的转子和输血泵11的动作。 控制器13具有根据通过第一管线21进入离心分离器20的血液量而在采血过程中改变转子142的旋转频率的功能。
    • 10. 发明授权
    • Curable liquid resin composition
    • 可固化液体树脂组合物
    • US6048953A
    • 2000-04-11
    • US000474
    • 1998-02-03
    • Miki KawashimaKunio HoriuchiHiroaki Tanaka
    • Miki KawashimaKunio HoriuchiHiroaki Tanaka
    • C08F265/06C08L55/00C09D4/02C09D4/06C09D11/10C09D155/00C08F220/10C08F220/18
    • C09D155/005C08F265/06C08L55/005C09D11/101C09D4/06
    • A curable liquid resin composition containing 100 parts by weight of the following (meth)acrylic liquid resin (A) and 1 to 1,000 parts by weight of a (meth)acrylic monomer (B) having an unsaturated double bond in its molecule and having a number average molecular weight of 1,000 or less, the (meth)acrylic liquid resin (A) being a liquid resin which is obtained by polymerizing monomers containing an alkyl (meth)acrylate monomer (a-1-1) of the formula (1),CH.sub.2 C(R.sup.1)COO--R.sup.2 (1)wherein R.sup.1 is a hydrogen atom or CH.sub.3 and R.sup.2 is an alkyl group,and/or an alkylene glycol (meth)acrylate monomer (a-1-2) of the formula (2),CH.sub.2 .dbd.C(R.sup.1)COO(C.sub.n H.sub.2n O).sub.m R.sup.3(2)wherein R.sup.1 is a hydrogen atom or CH.sub.3, R.sup.3 is an alkyl group or a phenyl group, n is an integer of 1 to 3, and m is an integer of 3 to 25, and other polymerizable vinyl monomer (a-2), an average of molecular weights of all the monomers being 100 to 1,500, the liquid resin having a number average molecular weight of 10,000 to 200,000 and a viscosity of 1 to 10,000 poise (measured at 50.degree. C.), or a modified product of the above liquid resin, the curable liquid resin composition can form a film as a film-forming material or as a resin for an adhesive without using a solvent and give a cured film.
    • PCT No.PCT / JP97 / 01871 Sec。 371日期1998年2月3日 102(e)1998年2月3日PCT 1997年6月2日PCT公布。 出版物WO97 / 46601 日期1997年12月11日含有100重量份以下(甲基)丙烯酸系液态树脂(A)和1〜1000重量份具有不饱和双键的(甲基)丙烯酸系单体(B)的固化性液态树脂组合物 其分子的数均分子量为1000以下,作为液状树脂的(甲基)丙烯酸系液态树脂(A)是将含有(甲基)丙烯酸烷基酯单体(a-1-1)的单体 式(1),其中R1是氢原子或CH3,R2是烷基的CH2(R)COO-R2(1),和/或亚烷基二醇(甲基)丙烯酸酯单体(a-1-2) 式(2)中,CH 2 = C(R 1)COO(C n H 2n O)m R 3(2)其中R 1为氢原子或CH 3,R 3为烷基或苯基,n为1〜3的整数, m为3〜25的整数,其它的聚合性乙烯基单体(a-2),所有单体的分子量平均为100〜1500,数均分子量为10,000〜200,000的液态树脂和vi 1〜10,000泊(50℃测定)的光泽度或上述液态树脂的改性物,可固化型液态树脂组合物可以形成作为成膜材料的膜或粘合剂用树脂,而不使用 溶剂,得到固化膜。